IP Library Granted Patent US 12,064,563
Granted Patent B2
US 12,064,563 · App. 18/154,280 · Granted Aug 20, 2024

Methods for enhancing exposure therapy using pairing with Vagus nerve stimulation

Inventors: Christa McIntyre Rodriguez (Richardson, TX); Navzer Dara Engineer (Plano, TX); Michael P. Kilgard (Richardson, TX)
Assignees: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM; MICROTRANSPONDER, INC.
A61M21/00A61N1/36017A61N1/36025A61N1/36053A61N1/36092A61N1/36096A61N1/361A61N1/36103G09B23/28A61M2021/0027A61M2021/0044A61M2021/0072A61M21/02A61N1/36082A61N1/36089
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,064,563
App. No.
18/154,280
Granted
Aug 20, 2024
Kind
B2
Abstract

A therapy method (for a patient having post-traumatic stress disorder (PTSD)) includes: providing an exposure event, to the patient, which is related to a traumatic event that contributed to the PTSD; and, during a therapy session which includes the exposure event, applying vagus nerve stimulation (VNS). A therapy method (for a patient having a given disorder, e.g., a phobia disorder or an obsessive-compulsive disorder (OCD) or an addiction disorder) includes: providing a therapy event (e.g., an extinction event for a phobia disorder), to the patient, which is related to one or more things that contributed to the given disorder; and during a therapy session which includes the therapy event, applying VNS.

Claims (44)

1. A therapy method for a patient having post-traumatic stress disorder (PTSD), the therapy method comprising:

providing an exposure event to the patient which is related to a traumatic event that contributed to the PTSD; and

providing vagus nerve stimulation to the patient electrically during a therapy session which includes the exposure event using a neurostimulator.

2. The method of claim 1 , wherein the therapy method is a memory extinction therapy method.

3. The method of claim 1 , wherein the vagus nerve stimulation has a stimulation intensity equal to or less than about 0.8 mA.

4. The method of claim 1 , wherein:

the exposure event includes a trigger event; and

timing of the vagus nerve stimulation is based on the trigger event.

5. The method of claim 1 , wherein the exposure event contains sensory recreations of a traumatic event.

6. The method of claim 1 , wherein the vagus nerve stimulation is performed electrically and invasively.

7. The method of claim 1 , wherein the providing an exposure event and the vagus nerve stimulation results in a reduction in symptoms of PTSD experienced by the patient.

8. The method of claim 1 , wherein the patient is a patient where the PTSD took months to develop following an initial exposure to a traumatic event that resulted in the PTSD.

9. The method of claim 1 , wherein the providing an exposure event and the vagus nerve stimulation occur long after a traumatic event that resulted in the PTSD.

10. The method of claim 1 , wherein the providing an exposure event and the vagus nerve stimulation facilitate a natural extinction process of the patient that protects most people from developing post-traumatic stress disorder.

11. The method of claim 1 , wherein the therapy method is a memory extinction therapy method, the memory extinction therapy method alleviating, at least in part, the post-traumatic stress disorder.

12. The method of claim 1 , wherein the vagus nerve stimulation has a stimulation duration of about 100 msec to about 30 sec.

13. The method of claim 1 , wherein the vagus nerve stimulation has a stimulation frequency of about 10 Hz to about 150 Hz.

14. A therapy method for a patient having a phobia disorder, therapy method comprising:

providing an extinction event to the patient which is related to something that contributed to the phobia disorder; and

providing vagus nerve stimulation to the patient electrically during a therapy session which includes the extinction event using a neurostimulator, thereby at least partially alleviating the phobia disorder.

15. The method of claim 14 , further comprising:

executing a retention test to determine a duration of an extinction of the phobia disorder.

16. The method of claim 14 , wherein the vagus nerve stimulation is performed electrically and invasively.

17. The method of claim 14 , wherein the vagus nerve stimulation has a stimulation intensity equal to or less than about 0.8 mA.

18. The method of claim 14 , wherein a duration of the vagus nerve stimulation is about 100 msec to about 30 sec.

19. The method of claim 14 , wherein a frequency of the vagus nerve stimulation is about 10 Hz to about 150 Hz.

20. The method of claim 14 , wherein the providing an extinction event and the vagus nerve stimulation results in a reduction in symptoms of the phobia disorder experienced by the patient.

21. A therapy method for a patient having an obsessive-compulsive disorder (OCD), the therapy method comprising:

providing a therapy event to the patient which is related to something that contributed to the OCD; and

providing vagus nerve stimulation to the patient electrically during a therapy session which includes the therapy event using a neurostimulator.

22. The method of claim 21 , wherein the providing a therapy event includes providing an exposure event to the patient.

23. The method of claim 22 , wherein the providing a therapy event and the vagus nerve stimulation results in a reduction in symptoms of the OCD experienced by the patient.

24. The method of claim 21 , wherein the vagus nerve stimulation is performed electrically and invasively.

25. The method of claim 21 , wherein the vagus nerve stimulation has a stimulation intensity equal to or less than about 0.8 mA.

26. The method of claim 21 , wherein the vagus nerve stimulation has a stimulation duration of about 100 msec to about 30 sec.

27. The method of claim 21 , wherein the vagus nerve stimulation has a stimulation frequency of about 10 Hz to about 150 Hz.

28. A therapy method for a patient having an addiction disorder, the therapy method comprising:

providing a therapy event to a patient which is related to one or more things that contributed to the addiction disorder; and

providing vagus nerve stimulation to the patient electrically during a therapy session which includes the therapy event using a neurostimulator.

29. The method of claim 28 , wherein the providing a therapy event includes providing an exposure event to the patient.

30. The method of claim 29 , wherein the providing a therapy event and the vagus nerve stimulation results in a reduction in symptoms of the addiction disorder experienced by the patient.

31. The method of claim 28 , wherein the vagus nerve stimulation has a stimulation intensity equal to or less than about 0.8 mA.

32. The method of claim 28 , wherein the vagus nerve stimulation has a stimulation duration of about 100 msec to about 30 sec.

33. The method of claim 28 , wherein the vagus nerve stimulation has a stimulation frequency of about 10 Hz to about 150 Hz.

Continuity (10)
Continuation 16284754 · Feb 25, 2019
Continuation 14808509 · Jul 24, 2015
Division 13095570 · Apr 27, 2011
Continuation In Part 12485040 · Jun 15, 2009
Provisional Application 61328621 · Apr 27, 2010
Provisional Application 61149387 · Feb 3, 2009
Provisional Application 61086116 · Aug 4, 2008
Provisional Application 61078954 · Jul 8, 2008
Provisional Application 61077648 · Jul 2, 2008
Related Publication 20230146775A1 · May 11, 2023